A method for the isolation and analysis of leucocytic cells from Leishmanial ear lesions in mice

Journal of Immunological Methods

Volumn 228, Issue 1-2, 1999, Pages 1-11

  DeKrey, Gregory K ^a   Titus, Richard G ^a  

^a Department of Clinical Sciences   (United States)

Author keywords

Ears; Flow cytometry; Leishmania; Lesions

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; EAR DISEASE; FEMALE; FLOW CYTOMETRY; LEISHMANIA MAJOR; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN LEISHMANIASIS;

ANIMALS; ANTIGENS, CD45; ANTIGENS, THY-1; CELL SEPARATION; DISEASE MODELS, ANIMAL; EAR; EVALUATION STUDIES; FEMALE; FLOW CYTOMETRY; GRANULOCYTES; IMMUNOPHENOTYPING; LEISHMANIASIS, CUTANEOUS; LEUKOCYTES; MICE; MICE, INBRED BALB C; T-LYMPHOCYTE SUBSETS;

EID: 0032703242     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(99)00085-X     Document Type: Article

References (34)

1. Babcock, G.F., Dawes, S.M., 1994. Immunophenotyping using fixed cells. In: Darzynkiewicz, Z., Robinson, J.P., Crissman, H.A. (Eds.), Methods in Cell Biology, Vol. 41, Chap. 5, Flow Cytometry, 2nd edn., Part A. Academic Press, San Diego, p. 84.
2. Beil W.J., Meinardus-Hager G., Neugebauer D.C., Sorg C. Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and susceptible mice. J. Leukocyte Biol. 52:1992;135.
3. Belkaid Y., Jouin H., Milon G. A method to recover, enumerate and identify lymphomyeloid cells present in an inflammatory dermal site: a study in laboratory mice. J. Immunol. Methods. 199:1996;5.
4. Belkaid Y., Kamhawi S., Modi G., Valenzuela J., Noben-Trauth N., Rowton E., Ribeiro J., Sacks D.L. Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long term outcome of Leishmania major infection in the mouse ear dermis. J. Exp. Med. 188:1998;1.
5. Bogdan C., Gessner A., Solbach W., Röllinghoff M. Invasion, control and persistence of Leishmania parasites. Curr. Opin. Immunol. 8:1996;517.
6. Diefenbach A., Schindler H., Donhauser N., Lorenz E., Laskay T., MacMicking J., Röllinghoff M., Gresser I., Bogdan C. Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity. 8:1998;77.
7. Fleming T.J., Fleming M.L., Malek T.R. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. J. Immunol. 151:1993;2399.
8. Green S.J., Meltzer M.S., Hibbs J.B. Jr., Nacy C.A. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 144:1990;278.
9. Heinzel F.P., Sadick M.D., Locksley R.M. Leishmania major: analysis of lymphocyte and macrophage cellular phenotypes during infection of susceptible and resistant mice. Exp. Parasitol. 65:1988;258.
10. Heinzel F.P., Schoenhaut D.S., Rerko R.M., Rosser L.E., Gately M.K. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1993;1505.
11. Hestdal K., Ruscetti F.W., Ihle J.H., Jacobsen S.E.W., Dubois C.M., Kopp W.C., Longo D.L., Keller J.R. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J. Immunol. 147:1991;22.
12. Holmberg L.A., Springer T.A., Ault K.A. Natural killer activity in the peritoneal exudates of mice infected with Listeria monocytogenes: characterization of the natural killer cells by using monoclonal rat anti-murine antibody (M1/70). J. Immunol. 127:1981;1792.
13. Kishimoto T.K., Jutila M.A., Berg E.L., Butcher E.C. Neutrophil, Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science. 245:1989;1238.
14. Kruisbeek, A.M., 1994. In: Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M., Strober, W. (Eds.), Current Protocols in Immunology, Vol. 1., Chap. 3, In Vitro Assays for Lymphocyte Function. Wiley, New York, p. 3.1.5.
15. Launois P., Maillard I., Pingel S., Swihart K.G., Xenarios I., Acha-Orbea H., Diggelmann H., Locksley R.M., MacDonald H.R., Louis J.A. IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity. 6:1997;541.
16. 2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-γ J. Immunol. 143:1989;3020.
17. Liew F.Y., O'Donnell C.A. Immunology of leishmaniasis. Adv. Parasitol. 32:1993;161.
18. Liew F.Y., Millott S., Li Y., Lelchuk R., Chan W.L., Ziltener H. Macrophage activation by interferon-γ from host-protective T cells is inhibited by interleukin (IL) 3 and IL-4 produced by disease-promoting T cells in leishmaniasis. Eur. J. Immunol. 19:1989;1227.
19. Liew F.Y., Millott S., Parkinson C., Palmer R.M.J., Moncada S. Macrophage killing of Leishmania parasites in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144:1990;4794.
20. Lohoff M., Gessner A., Bogdan C., Röllinghoff M. The Th-1/Th-2 paradigm and experimental murine leishmaniasis. Int. Arch. Allergy Immunol. 115:1998;191.
21. Mackay C.R., Marston W., Dudler L. Altered patterns of T cell migration through lymph nodes and skin following antigen challenge. Eur. J. Immunol. 22:1992;2205.
22. Mauel J., Ransijn A., Buchmuller-Rouiller Y. Killing of Leishmania parasites in activated murine macrophages is based on an L-arginine-dependent process that produces nitrogen derivatives. J. Leuk. Biol. 49:1991;73.
23. McElrath J., Kaplan G., Nusrat A., Cohn Z. Cutaneous leishmaniasis: the defect in T cell influx in BALB/c mice. J. Exp. Med. 165:1987;546.
24. Muller, R., Baker, J.R., 1990. Medical Parasitology. Gower Medical Publishing, New York, p. 37.
25. Picker L.J., Butcher E.C. Physiological and molecular mechanisms of lymphocyte homing. Annu. Rev. Immunol. 10:1992;561.
26. Reiner S.L., Locksley R.M. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:1995;151.
27. Sacks D.L., Perkins P.V. Identification of an infectious stage of Leishmania promastigotes. Science. 223:1984;1417.
28. Sher A., Gazzinelli R.T., Oswald I.P., Clerici M., Kullberg M., Pearce E.J., Berzofsky J.A., Mosmann T.R., James S.L., Morse H.C. Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol. Rev. 127:1992;183.
29. Springer T., Galfré G., Secher D.S., Milstein C. Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur. J. Immunol. 9:1979;301.
30. Stenger S., Thuring H., Röllinghoff M., Bogdan C. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180:1994;783.
31. Sunderkötter C., Kunz M., Steinbrink K., Meinardus-Hager G., Goebeler M., Bildau H., Sorg C. Resistance of mice to experimental leishmaniasis is associated with more rapid appearance of mature macrophages in vitro and in vivo. J. Immunol. 151:1993;4891.
32. Sypek J.P., Chung C.L., Mayor S.E., Subramanyam J.M., Goldman S.J., Sieburth D.S., Wolf S.F., Schaub R.G. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1993;1797.
33. Titus R.G., Ceredig R., Cerottini J.C., Louis J.A. Therapeutic effect of anti-L3T4 antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. J. Immunol. 135:1985;2108.
34. von Stebut E., Belkaid Y., Jakob T., Sacks D., Udey M.C. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J. Exp. Med. 188:1998;1547.